【摘要】 目的　探讨硬化剂囊内注射治疗甲状腺良性囊性病变的可行性。　方法　回顾性分析 6 0例甲状腺囊性病变穿刺注入无水乙醇或 10 %氯化钠硬化治疗的临床资料。　结果　 6 0例中共 74个病灶 ,共行穿刺硬化治疗 182次 ,无并发症发生 ,总治愈率 98 3% (5 9 6 0 )。全组均获随访 ,时间 1年～ 5年 ,平均 2年 ,无复发。　结论　硬化剂囊内注射治疗甲状腺良性囊性病变可行 ,其应用前提是须排除甲状腺囊性乳头状癌。更多还原

【Abstract】 Objective To investigate the feasibility of sclerosing agent injection in the treatment of benign thyroid cysts. Methods Clinical data of 60 patients with thyroid cysts, who had been treated by injection of absolute alcohol or 10% sodium chloride solution, were reviewed retrospectively. Results A total of 74 lesions existed in 60 patients, and 182 times of injection were performed, with a total cure rate of 98 3% (59/60). No complications occurred. Follow-up observations for 1～5 years (mean 2 years) found no recurrence. Conclusions Sclerosing agent injection is a feasible method for benign thyroid cysts, if an exclusion of cystic papillary carcinoma is made.更多还原